Manos, Maylessa .
HRN: 28-58-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/23/2026
CEFUROXIME 500MG (TAB)
02/23/2026
02/28/2026
PO
500 Mg
BID
UTI
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: